TA
PVLA

Teachers Advisors’s Palvella Therapeutics PVLA Stock Holding History

Teachers Advisors’s Portfolio PVLA Stock Details PVLA Fund Activity
Bought
Maintained
Sold
Quarter Market Value Status Shares Change in
Stake 		Trade Value Portfolio Weight Portfolio Position
2019
Q1 		$1.64M Buy
6,135
+5,091
+488% +$1.21M ﹤0.01% 2068
2018
Q4 		$222K Hold
1,044
– – ﹤0.01% 2814
2018
Q3 		$468K Sell
1,044
-7
-0.7% -$3.04K ﹤0.01% 2665
2018
Q2 		$426K Buy
1,051
+290
+38% +$138K ﹤0.01% 2727
2018
Q1 		$415K Hold
761
– – ﹤0.01% 2613
2017
Q4 		$460K Hold
761
– – ﹤0.01% 2598
2017
Q3 		$351K Hold
761
– – ﹤0.01% 2743
2017
Q2 		$308K Buy
+761
New +$222K ﹤0.01% 2851

Other funds holding PVLA

BI
BVF Inc San Francisco, California $3.14B AUM 249.53% 1-Year Est. Return
BlackRock
BlackRock New York $5.72T AUM 30.48% 1-Year Est. Return
Acadian Asset Management
Acadian Asset Management Boston, Massachusetts $70.5B AUM 36% 1-Year Est. Return
Renaissance Technologies
Renaissance Technologies New York $63.9B AUM 45.56% 1-Year Est. Return
TCM
Tekla Capital Management Boston, Massachusetts $2.56B AUM 18.15% 1-Year Est. Return
NCM
Nantahala Capital Management New Canaan, Connecticut $2.72B AUM 121.58% 1-Year Est. Return
ACM
Aquilo Capital Management San Francisco, California $55.8M AUM 41.76% 1-Year Est. Return
State Street
State Street Boston, Massachusetts $2.9T AUM 29.55% 1-Year Est. Return
OFM
Omega Fund Management Boston, Massachusetts $163M AUM 107.06% 1-Year Est. Return
American Century Companies
American Century Companies Kansas City, Missouri $194B AUM 35% 1-Year Est. Return

Teachers Advisors's PVLA Position: Q1 2019 in Review

Teachers Advisors increased its Palvella Therapeutics (PVLA) stake by 488% in Q1 2019, buying an estimated $1.21M and bringing the position to 6,135 shares worth $1.64M. The position accounts for ﹤0.01% of the portfolio, ranked #2068.

Teachers Advisors first reported a position in PVLA in Q2 2017 and has held it in 8 quarters since. 92 funds tracked by Wall St. Rank hold PVLA as of Q1 2019.

  • Teachers Advisors held 6,135 shares of Palvella Therapeutics worth $1.64M as of Q1 2019.
  • Teachers Advisors bought 5,091 Palvella Therapeutics shares in Q1 2019, an estimated $1.21M.
  • Palvella Therapeutics made up ﹤0.01% of Teachers Advisors's portfolio in Q1 2019, its #2068 holding.
  • Teachers Advisors first reported a position in Palvella Therapeutics in Q2 2017 and has held it in 8 quarters since.
  • 92 funds tracked by Wall St. Rank held Palvella Therapeutics as of Q1 2019.

Based on Teachers Advisors's 13F filing for Q1 2019, filed 14 May 2019.